Generated by AI
Supernus, Inc. is a diversified biopharmaceutical company focused on developing and commercializing medicines for central nervous system disorders. Its current portfolio addresses opioid use disorder, attention-deficit hyperactivity disorder, Parkinson’s disease-related motor complications, postpartum depression, epilepsy, migraine, cervical dystonia, and chronic sialorrhea. Key products include SUBLOCADE, a long-acting buprenorphine injection for opioid use disorder; Qelbree for ADHD; GOCOVRI for Parkinson’s disease dyskinesia; ONAPGO for Parkinson’s disease-related hypomobility; and ZURZUVAE for postpartum depression. The company combines specialty pharmaceutical development, regulatory expertise, manufacturing, and commercial distribution to serve patients, healthcare professionals, pharmacies, and treatment providers. Its business spans psychiatry, neurology, and addiction medicine, giving it a broad role within the specialty pharmaceutical market. Supernus, Inc. supports treatment areas where sustained medication delivery, differentiated formulations, and focused clinical applications can help address complex neurological and behavioral health needs.
Website10710 Midlothian Turnpike
North Chesterfield, VA, 23235
United States
The latest articles about INDV.
Supernus Pharmaceuticals (SUPN) just completed its all‑stock merger with Indivior Pharmaceuticals, creating Supernus, Inc., and simultaneously requested delisting of its legacy shares after multiple index removals connected to the transaction. Recent trading tells a mixed story for Supernus Pharmaceuticals. The share price closed at $41.92 after a 7 day share price return of 2.34%, yet the 90 day share price return declined 10.64% and the 1 year total shareholder return fell 26.46%. However,...
The company is merging with a peer.
Summary of Oct 29's posts. Generated by AI.
No summary yet.
Summary of Nov 3's posts. Generated by AI.
No summary yet.
Summary of Aug 3's posts. Generated by AI.
Investors talking about INDV also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.